ORIGINAL RESEARCH
Accepted on 28 Jul 2025
The Silent Signals: Emerging Safety Concerns in Bispecific Antibody Therapy for Multiple Myeloma
doi 10.3389/fmed.2025.1593405
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Understanding and Controlling Adverse Effects in Myeloma Patients treated with T Cell Redirecting Immunotherapies
Understanding and Controlling Adverse Effects in Myeloma Patients treated with T Cell Redirecting Immunotherapies
710
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: